tiprankstipranks
Trending News
More News >
Entheon Biomedical Corp. (ENTBF)
:ENTBF

Entheon Biomedical (ENTBF) Price & Analysis

Compare
34 Followers

ENTBF Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

15.59%84.41%
15.59% Insiders
― Other Institutional Investors
84.41% Public Companies and
Individual Investors

ENTBF FAQ

What was Entheon Biomedical Corp.’s price range in the past 12 months?
Entheon Biomedical Corp. lowest stock price was $0.02 and its highest was $0.29 in the past 12 months.
    What is Entheon Biomedical Corp.’s market cap?
    Entheon Biomedical Corp.’s market cap is $1.20M.
      When is Entheon Biomedical Corp.’s upcoming earnings report date?
      Entheon Biomedical Corp.’s upcoming earnings report date is Jul 29, 2025 which is in 93 days.
        How were Entheon Biomedical Corp.’s earnings last quarter?
        Currently, no data Available
        Is Entheon Biomedical Corp. overvalued?
        According to Wall Street analysts Entheon Biomedical Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Entheon Biomedical Corp. pay dividends?
          Entheon Biomedical Corp. does not currently pay dividends.
          What is Entheon Biomedical Corp.’s EPS estimate?
          Entheon Biomedical Corp.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Entheon Biomedical Corp. have?
          Entheon Biomedical Corp. has 13,858,926 shares outstanding.
            What happened to Entheon Biomedical Corp.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Entheon Biomedical Corp.?
            Currently, no hedge funds are holding shares in ENTBF
            ---

            Company Description

            Entheon Biomedical Corp.

            Entheon Biomedical Corp is a biotechnology research and development company. It is committed towards developing and safe and effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders. It generates revenue through the sale of products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Numinus Wellness
            Neo Performance Materials Inc
            Cybin
            Red Light Holland
            HAVN Life Sciences
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis